Goodman leaving Pfizer

Pfizer Inc. (NYSE:PFE) said in an SEC filing on Monday that Corey Goodman resigned as SVP and president of the pharma's Biotherapeutics and Bioinnovation Center, effective May 31. Rodney Lappe, who is CSO of the center's CovX Research LLC unit, will replace Goodman. ...